Healthcare’s Challenging Trio: Quality, Safety, and Complexity
Assessing Value/Calculating ROI HIT Summit Pre-conference II: Health Information Technology Implementation: Capital, Reimbursement and Payment Incentives,
Is FDA failing us Or are we failing FDA? Jonathan C. Javitt, M.D.,M.P.H Senior Fellow, Potomac Institute for Policy Studies Former Chair, Health Subcommittee,
George Davies, Global Clinical Safety Lead, CSC - eMM Systems and Clinical Risk Management: The Suppliers Role
Regulatory Training Interpreter Services. Learning Objectives Upon completion of this training, you will be able to: Recognize the legal and ethical obligations.
An ABC of Drug-Related Problems
An ABC of Drug-Related Problems RHB Meyboom, M Lindquist, ACG Egberts Drug Safety 2000;22:415-23.
The Pharma/Biotech Conundrum: R & D Spending Up, No. of Drugs Down INFORMS October 13, 2009
Regulatory Training
